HDAC9 and cancer: In line with the mRNA data, LBH589 and pirfenidone effectively decreased protein expression of survivin as compared to vehicle (Fig 8A and 8B), but suppression of this cancer-specific protein was more effective in response to the strong pan-HDAC inhibitor LBH589 (Fig 8A).